Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis

World Journal of Gastroenterology

Volumn 16, Issue 4, 2010, Pages 484-489

  Akiyama, Tomoyuki ^a   Inamori, Masahiko ^a   Iida, Hiroshi ^a   Endo, Hiroki ^a   Hosono, Kunihiro ^a   Sakamoto, Yasunari ^a   Fujita, Koji ^a   Yoneda, Masato ^a   Takahashi, Hirokazu ^a   Koide, Tomoko ^a   Tokoro, Chikako ^a   Goto, Ayumu ^a   Abe, Yasunobu ^a   Shimamura, Takeshi ^a   Kobayashi, Noritoshi ^a   Kubota, Kensuke ^a   Saito, Satoru ^a   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Barrett's epithelium; Endoscopy; Esophagitis

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT EPITHELIUM; BARRETT ESOPHAGUS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ESOPHAGUS MUCOSA; FEMALE; GASTROINTESTINAL ENDOSCOPY; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; REFLUX ESOPHAGITIS;

EID: 76149119735     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i4.484     Document Type: Article

References (30)

1. Mann NS, Tsai MF, Nair PK. Barrett's esophagus in patients with symptomatic reflux esophagitis. Am J Gastroenterol 1989; 84: 1494-1496
2. Winters C Jr, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF 3rd, Johnson DA, Cruess DF, Cotelingam JD, Gurney MS. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92: 118-124
3. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 645-654
4. Powell J, McConkey CC, Gillison EW, Spychal RT. Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer 2002; 102: 422-427
5. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA 1993; 270: 1320
6. Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol 2003; 38 Suppl 15: 25-30
7. Lassen A, Hallas J, de Muckadell OB. Esophagitis: incidence and risk of esophageal adenocarcinoma - a population-based cohort study. Am J Gastroenterol 2006; 101: 1193-1199
8. Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-831
9. Farrow DC, Vaughan TL, Sweeney C, Gammon MD, Chow WH, Risch HA, Stanford JL, Hansten PD, Mayne ST, Schoenberg JB, Rotterdam H, Ahsan H, West AB, Dubrow R, Fraumeni JF Jr, Blot WJ. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 2000; 11: 231-238
10. Wu AH, Tseng CC, Bernstein L. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer 2003; 98: 940-948
11. Ye W, Chow WH, Lagergren J, Yin L, Nyrén O. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology 2001; 121: 1286-1293
12. Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, Jankowski JA, Junghard O, Lundell L, Tytgat GN, Vieth M. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392-1399
13. Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, Tytgat GN, Wallin L. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 85-92
14. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 3: 87-97
15. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furiha ta C, Matsushima T, Takahashi K. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987; 22: 133-141
16. O'Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, Keeling PW, Kelleher D, Reynolds JV. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia- adenocarcinoma sequence in the esophagus. Am J Gastroenterol 2005; 100: 1257-1264
17. Fitzgerald RC, Abdalla S, Onwuegbusi BA, Sirieix P, Saeed IT, Burnham WR, Farthing MJ. Inflammatory gradient in Barrett's oesophagus: implications for disease complications. Gut 2002; 51: 316-322
18. Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, Saeed IT, Burnham WR, Farthing MJ. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 2002; 50: 451-459
19. Tselepis C, Perry I, Dawson C, Hardy R, Darnton SJ, McConkey C, Stuart RC, Wright N, Harrison R, Jankowski JA. Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action. Oncogene 2002; 21: 6071-6081
20. Amano Y, Kushiyama Y, Yuki T, Takahashi Y, Moriyama I, Fukuhara H, Ishimura N, Furuta K, Ishihara S, Adachi K, Maruyama R, Kinoshita Y. Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype. Scand J Gastroenterol 2006; 41: 873-879
21. Akiyama T, Inamori M, Akimoto K, Iida H, Mawatari H, Endo H, Ikeda T, Nozaki Y, Yoneda K, Sakamoto Y, Fujita K, Yoneda M, Takahashi H, Hirokawa S, Goto A, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Nakajima A. Risk factors for the progression of endoscopic Barrett's epithelium in Japan: a multivariate analysis based on the Prague C & M Criteria. Dig Dis Sci 2009; 54: 1702-1707
22. Sharma P, Morales TG, Sampliner RE. Short segment Barrett's esophagus-the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol 1998; 93: 1033-1036
23. Hamilton SR, Smith RR. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987; 87: 301-312
24. Yamagishi H, Koike T, Ohara S, Kobayashi S, Ariizumi K, Abe Y, Iijima K, Imatani A, Inomata Y, Kato K, Shibuya D, Aida S, Shimosegawa T. Tongue-like Barrett's esophagus is associated with gastroesophageal reflux disease. World J Gastroenterol 2008; 14: 4196-4203
25. Oberg S, DeMeester TR, Peters JH, Hagen JA, Nigro JJ, DeMeester SR, Theisen J, Campos GM, Crookes PF. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg 1999; 117: 572-580
26. Wakelin DE, Al-Mutawa T, Wendel C, Green C, Garewal HS, Fass R. A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc 2003; 58: 350-355
27. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus. Dig Dis Sci 2002; 47: 256-264
28. Harle IA, Finley RJ, Belsheim M, Bondy DC, Booth M, Lloyd D, McDonald JW, Sullivan S, Valberg LS, Watson WC. Management of adenocarcinoma in a columnar-lined esophagus. Ann Thorac Surg 1985; 40: 330-336
29. Ransom JM, Patel GK, Clift SA, Womble NE, Read RC. Extended and limited types of Barrett's esophagus in the adult. Ann Thorac Surg 1982; 33: 19-27
30. Menke-Pluymers MB, Hop WC, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 1993; 72: 1155-1158